$ACHN News 10 Nasdaq stocks with returns of at least

New Post Public Reply Private Reply Replies (0) Message Board

Oct 8, 2014 at 11:20 AM

$ACHN News

10 Nasdaq stocks with returns of at least 240% in 2014 5:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 1:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 11:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 4:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 9:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 10:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 8:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 5:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 5:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 3:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 5:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 9:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 10:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 10:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 10:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 12:56 p.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 5:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy

Top 5 Biotech Stocks Over The Past Year 1:28 p.m. Oct. 6, 2014 - benzinga.com
Insider Selling Jumps as Market Volatility Highest Since Summer 8:23 a.m. Oct. 4, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – ACHN THRX AGN VRTX 1:30 p.m. Oct. 3, 2014 - InvestorPlace.com
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma 9:41 a.m. Oct. 3, 2014 - TheStreet.com
Achillion: Positioned To Deliver The Last Clinical Stage Nuc To The Highest Bidder 2:48 p.m. Oct. 2, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/1/14: SNTA, AGCO, RSG, DWA 8:28 a.m. Oct. 2, 2014 - Seeking Alpha
Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal 11:19 a.m. Sept. 30, 2014 - benzinga.com
J&J Buying Alios, Going Up Against Gilead 11:02 a.m. Sept. 30, 2014 - Investors Business Daily
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax 9:49 a.m. Sept. 30, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/26/14: CONN, AEO, OPK, RSG 9:20 a.m. Sept. 29, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/23/14: Apple, Ulta, Intersections, Republic Services 10:42 a.m. Sept. 24, 2014 - Seeking Alpha
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks 5:00 a.m. Sept. 16, 2014 - TheStreet.com
Momentum Stocks Showing Weakness 4:33 p.m. Sept. 15, 2014 - benzinga.com
Midday Losers From September 15 - Tesla Motors Inc, Digital Ally, Inc. And More 11:56 a.m. Sept. 15, 2014 - benzinga.com
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks 10:59 a.m. Sept. 15, 2014 - 247WallSt.com
Morning Market Losers 8:48 a.m. Sept. 15, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Sept. 15, 2014 - benzinga.com

Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 56 min ago - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 9:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 9:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 9:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 8:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 8:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver 9:31 a.m. Aug. 26, 2014 - PR Newswire - PRF
Biotechnology Stocks to Keep an Eye On 9:02 a.m. Aug. 20, 2014 - ACCESSWIRE
New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo 8:40 a.m. Aug. 20, 2014 - PR Newswire - PRF
Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors 4:06 p.m. Aug. 19, 2014 - GlobeNewswire
Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV ("Proxy Study"

7:00 a.m. Aug. 15, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Achillion Reports Second Quarter and Six Month 2014 Financial Results 4:06 p.m. Aug. 7, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. July 10, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes 4:06 p.m. July 1, 2014 - GlobeNewswire
Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. June 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ADT Shareholders Face Legal Scrutiny in M&A Deal

ADT Shareholders on High Alert Listen up, folks. Anyone holding shares in ADT Inc. (NYSE: ADT) needs to sharpen their pencils and start crunching numbers. This isn't the time to sit back and coast. A M&A Class Action investigation is brewing, and it's centered on ADT's sale to Thrive Holdings. The $10.00 per share buyout offer might look neat and tidy, but there's more to...

Main Street Merger Faces Scrutiny: What It Means for Shareholders

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Haunted Attraction Insights from the Queen of Haunts

Admit it—everyone's got that one fear that sends shivers down their spine. Whether it's the slithering scales of a snake or the manic laughter of a clown, those phobias are what make haunted attractions such a hit for thrillseekers across the country. Amber Arnett-Bequeaith, the so-called Queen of Haunts, knows a thing or two about turning those fears into unforgettable...

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Neuberger Fund Ups Distribution Amid Market Challenges

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Fluence Energy Faces Class Action: Investors Beware

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

BCD Travel Faces Class Action Probe After Data Breach

Class Action Stirred by BCD Travel Data Breach Here's the scoop, folks: Edelson Lechtzin LLP, a heavyweight in the world of class action law firms, is sniffing around BCD Travel Services B.V. over a juicy data breach that left about 700,000 traveler records flapping in the wind. Grab your coffee—this one's got all the trimmings of a modern-day digital fiasco. The Breach...

Rural AI Skills Gap Uncovered: Challenges and Solutions

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...